Hepatitis C Community
13.3k Members
Avatar universal

A Interesting Study in the State of Florida

February 20, 2006
A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient therapy will be coming soon.


By Libby Fairhurst
February 7, 2006

TALLAHASSEE, Fla. --The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for experimental research.

Now, in a landmark study by Florida State University biologists that could bolster the development of anti-viral therapies for HCV -- as well as for related RNA viruses such as West Nile and influenza -- Assistant Professor Hengli Tang and doctoral student/co-author Heather B. Nelson have discovered the molecular mechanism that inhibits HCV replication in vitro after its host cells become crowded and stopped dividing.

What's more, their groundbreaking discovery came about as a result of the new test they developed that can quickly and easily monitor HCV replication in the laboratory. Finally, after Tang and Nelson uncovered the reason for suppression of the virus in cell culture -- in a nutshell: not enough nucleotide molecules, the building blocks of HCV -- they then adapted an existing cell technology to remedy the problem right in the test tube.

The Tang-Nelson study and a description of the innovative technologies they devised to enable and track it will appear in the Feb. 8 edition of the Journal of Virology."Our findings could prove critical to research on HCV's complex virus-host cell interactions and lead to better, targeted treatments," Tang said. "Currently, any nucleotide starvation therapies, used primarily to treat cancer, can inhibit replication by depriving viral agents of their molecular building blocks. However, those therapies may impact healthy cells, as well, causing undesired side effects."

In the human liver, the parasitic HCV makes copies of its genetic material by hijacking nucleotides -- the little molecules produced by its dividing host cells. It is only in the liver that pools of nucleotides remain available to HCV in sufficient supply after the host cells reached confluence (stop dividing). Not so in test tubes, say the FSU researchers.

To address the shortage of HCV building blocks in vitro, their unique adaptation of an existing cell technology enabled the introduction of nucleoside molecules to a culture of liver cancer cells. The nucleosides then converted to the essential nucleotide molecules that Tang calls the missing link. In turn, the nucleotides generated in vitro replication of infectious HCV particles that continued even after host cell confluence -- as it does in the liver.

That's not all. "Our new cell line also allows us to rapidly identify and isolate drug-resistant HCV mutants in vitro and to screen for anti-viral drug candidates," Tang said. "This will help researchers better study the mechanism of drug resistance, a big problem with this virus and others such as HIV (human immunodeficiency virus) that mutate quickly."

Underpinning everything, Tang says, is their novel, easy-to-use assay. It can track mutant strains of HCV in a week or less while other assays take weeks or months.

"Our assay, for which FSU has filed a provisional patent application, employs a new reporter cell line, which means the cells give out a detectable signal when certain events happen inside them," said Tang. "In this case, they emit a green fluorescence whenever HVC is replicating. The fluorescence is tracked in the cell culture through a technique known as flow cytometry, which employs a machine equipped with a laser and lights that follows the green to find the virus."

Between earning his PhD at the University of California-San Diego in 1998 and joining FSU's biological science faculty in 2004, Tang served as a lead researcher in an industry setting, seeking targeted anti-viral therapies primarily for HIV.

"I find it particularly rewarding to play a part in research that may actually help somebody soon," he said.

The Tang-Nelson study at FSU -- "Effect of Cell Growth on Hepatitis C Virus (HCV) Replication and a Mechanism of Cell Confluence-Based Inhibition of HCV RNA and Protein Expression" -- was supported in part by a grant from the American Heart Association.

8 Responses
116701 tn?1210262764
Great information Upbeat and thanks for posting it. Dale
Avatar universal
Thanks for posting!!
92903 tn?1309908311
I got a full copy of the study we were discussing a few threads down. If anyone wants a copy, slip me your email, and I'll do that.
Avatar universal
PCR= ???
86075 tn?1238118691
Hey, thanks for posting this! Really interesting!

Goof: naaah you don't have to send me that study..but I could always use a coupla hundred bucks!...he he he! btw...Califia found it, far be it from me to take credit for someone elses sleuthing...

too bad you didn't get pictures of the snow in San Francisco (as ephemeral as it was)...or Stinson Beach or where ever you live...yeah, it's postively artic on the Left Coast huh? burrrrr...it's 51 here! (2Irish from Chicago is going to kill me for being such a weenie!)
92903 tn?1309908311
Kudos to you two for ferreting out that study. Now can anyone tease numbers out that address SVR rates for high VL, geno 3, with RVR, and EOT response? Or I guess relapse rates for that population would br a more direct way of posing the same  question. That number seems to be kinda burried in there.

Think I may email Dr Von Wagner and see if he will provide a breakdown.
Avatar universal
I would love a full coy.  This is good news. Thanks

Avatar universal
I went to the doctor yesterday and he told me that my viral load is over 9 million and that my liver function is normal.  I was wondering if anyone else has had the same.
Have an Answer?
Top Hepatitis Answerers
317787 tn?1473362051
683231 tn?1467326617
Auburn, WA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Answer a few simple questions about your Hep C treatment journey.

Those who qualify may receive up to $100 for their time.
Explore More In Our Hep C Learning Center
image description
Learn about this treatable virus.
image description
Getting tested for this viral infection.
image description
3 key steps to getting on treatment.
image description
4 steps to getting on therapy.
image description
What you need to know about Hep C drugs.
image description
How the drugs might affect you.
image description
These tips may up your chances of a cure.
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Here’s how your baby’s growing in your body each week.
These common ADD/ADHD myths could already be hurting your child
This article will tell you more about strength training at home, giving you some options that require little to no equipment.
In You Can Prevent a Stroke, Dr. Joshua Yamamoto and Dr. Kristin Thomas help us understand what we can do to prevent a stroke.
Smoking substitute may not provide such a healthy swap, after all.